{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:52:15Z","timestamp":1791899535134,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["201809PJT-409964-BCA-CBAA-193679"],"award-info":[{"award-number":["201809PJT-409964-BCA-CBAA-193679"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT\u2010178103"],"award-info":[{"award-number":["PJT\u2010178103"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MRC\u2010177440"],"award-info":[{"award-number":["MRC\u2010177440"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","award":["ND-10"],"award-info":[{"award-number":["ND-10"]}],"id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","award":["ND-20"],"award-info":[{"award-number":["ND-20"]}],"id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","award":["ATOP-17"],"award-info":[{"award-number":["ATOP-17"]}],"id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019889","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["RR202173"],"award-info":[{"award-number":["RR202173"]}],"id":[{"id":"10.13039\/100019889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","award":["21-04"],"award-info":[{"award-number":["21-04"]}],"id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship"],"award-info":[{"award-number":["Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["CGS-M"],"award-info":[{"award-number":["CGS-M"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DGECR-2018-00142"],"award-info":[{"award-number":["DGECR-2018-00142"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010322","name":"Stollery Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","award":["Graduate Studentship"],"award-info":[{"award-number":["Graduate Studentship"]}],"id":[{"id":"10.13039\/100010322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["38985"],"award-info":[{"award-number":["38985"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Microglia play diverse pathophysiological roles in Alzheimer\u2019s disease (AD), with genetic susceptibility factors skewing microglial cell function to influence AD risk. CD33 is an immunomodulatory receptor associated with AD susceptibility through a single nucleotide polymorphism that modulates mRNA splicing, skewing protein expression from a long protein isoform (CD33M) to a short isoform (CD33m). Understanding how human CD33 isoforms differentially impact microglial cell function in vivo has been challenging due to functional divergence of CD33 between mice and humans. We address this challenge by studying transgenic mice expressing either of the human CD33 isoforms crossed with the 5XFAD mouse model of amyloidosis and find that human CD33 isoforms have opposing effects on the response of microglia to amyloid-\u03b2 (A\u03b2) deposition. Mice expressing CD33M have increased A\u03b2 levels, more diffuse plaques, fewer disease-associated microglia, and more dystrophic neurites compared to 5XFAD control mice. Conversely, CD33m promotes plaque compaction and microglia-plaque contacts, and minimizes neuritic plaque pathology, highlighting an AD protective role for this isoform. Protective phenotypes driven by CD33m are detected at an earlier timepoint compared to the more aggressive pathology in CD33M mice that appears at a later timepoint, suggesting that CD33m has a more prominent impact on microglia cell function at earlier stages of disease progression. In addition to divergent roles in modulating phagocytosis, scRNAseq and proteomics analyses demonstrate that CD33m\n                    <jats:sup>+<\/jats:sup>\n                    microglia upregulate nestin, an intermediate filament involved in cell migration, at plaque contact sites. Overall, our work provides new functional insights into how CD33, as a top genetic susceptibility factor for AD, modulates microglial cell function.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13024-024-00734-8","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:01:34Z","timestamp":1716768094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Alzheimer\u2019s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice"],"prefix":"10.1186","volume":"19","author":[{"given":"Ghazaleh","family":"Eskandari-Sedighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Crichton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Gomez-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo M.","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takahashi-Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris D.","family":"St. Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Aghanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie L.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Plemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-1048","authenticated-orcid":false,"given":"Matthew S.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"734_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer\u2019s disease. Lancet. 2011;377:1019\u201331.","journal-title":"Lancet"},{"key":"734_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease European journal of neurology. 2018;25:59\u201370.","journal-title":"Alzheimer's disease European journal of neurology"},{"key":"734_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1076\/jhin.11.4.325.8531","volume":"11","author":"P Rezaie","year":"2002","unstructured":"Rezaie P, Male D. Mesoglia & microglia\u2013a historical review of the concept of mononuclear phagocytes within the central nervous system. J Hist Neurosci. 2002;11:325\u201374.","journal-title":"J Hist Neurosci"},{"key":"734_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CD Lee","year":"2010","unstructured":"Lee CD, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm. 2010;117:949\u201360.","journal-title":"J Neural Transm"},{"key":"734_CR5","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Investig. 2017;127:3240\u20139.","journal-title":"J Clin Investig"},{"key":"734_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23:1018\u201327.","journal-title":"Nat Med"},{"key":"734_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease. PLoS ONE. 2010;5: e13950.","journal-title":"PLoS ONE"},{"key":"734_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43:429\u201335.","journal-title":"Nat Genet"},{"key":"734_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43:436\u201341.","journal-title":"Nat Genet"},{"key":"734_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130419","volume":"10","author":"KM Hayden","year":"2015","unstructured":"Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Effect of APOE and CD33 on cognitive decline. PLoS ONE. 2015;10: e0130419.","journal-title":"PLoS ONE"},{"key":"734_CR11","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S. CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci. 2013;33:13320\u20135.","journal-title":"J Neurosci"},{"key":"734_CR12","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/hmg\/ddt666","volume":"23","author":"T Raj","year":"2014","unstructured":"Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE, Bennett DA, Evans DA. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer\u2019s disease susceptibility. Hum Mol Genet. 2014;23:2729\u201336.","journal-title":"Hum Mol Genet"},{"key":"734_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16:848\u201350.","journal-title":"Nat Neurosci"},{"key":"734_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-019-02000-4","volume":"138","author":"S Estus","year":"2019","unstructured":"Estus S, Shaw BC, Devanney N, Katsumata Y, Press EE, Fardo DW. Evaluation of CD33 as a genetic risk factor for Alzheimer\u2019s disease. Acta Neuropathol. 2019;138:187\u201399.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"734_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-021-00443-6","volume":"16","author":"A Bhattacherjee","year":"2021","unstructured":"Bhattacherjee A, Jung J, Zia S, Ho M, Eskandari-Sedighi G, St. Laurent CD, McCord KA, Bains A, Sidhu G, Sarkar S. The CD33 short isoform is a gain-of-function variant that enhances A\u03b2 1\u201342 phagocytosis in microglia. Mol Neurodegener. 2021;16(1):19.","journal-title":"Mol Neurodegener"},{"key":"734_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15349","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Thornton P, Brown GC. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer\u2019s disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion. J Neurochem. 2021;158:297\u2013310.","journal-title":"J Neurochem"},{"key":"734_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1073\/pnas.1517951112","volume":"113","author":"F Schwarz","year":"2016","unstructured":"Schwarz F, Springer SA, Altheide TK, Varki NM, Gagneux P, Varki A. Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline. Proc Natl Acad Sci. 2016;113:74\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"734_CR18","doi-asserted-by":"crossref","unstructured":"Eskandari-Sedighi G, Jung J, Macauley MS. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe. Mol Asp Med. 2022:101111.","DOI":"10.1016\/j.mam.2022.101111"},{"key":"734_CR19","doi-asserted-by":"crossref","unstructured":"Bhattacherjee A, Rodrigues E, Jung J, Luzentales-Simpson M, Enterina JR, Galleguillos D, St. Laurent CD, Nakhaei-Nejad M, Fuchsberger FF, Streith L. Repression of phagocytosis by human CD33 is not conserved with mouse CD33. Commun Biol.\u00a02019, 2:450.","DOI":"10.1038\/s42003-019-0698-6"},{"key":"734_CR20","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"issue":"3","key":"734_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1172\/JCI125456","volume":"129","author":"S Duan","year":"2021","unstructured":"Duan S, Koziol-White CJ, Jester WF, Smit SA, Nycholat CM, Macauley MS, Panettieri RA, Paulson JC. CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen. J Clin Investig. 2021;129(3):1387\u2013401.","journal-title":"J Clin Investig"},{"key":"734_CR22","first-page":"503","volume":"147","author":"ML Schmidt","year":"1995","unstructured":"Schmidt ML, Robinson KA, Lee V, Trojanowski JQ. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer\u2019s disease and Down\u2019s syndrome brains revealed by confocal microscopy. Am J Pathol. 1995;147:503.","journal-title":"Am J Pathol"},{"key":"734_CR23","doi-asserted-by":"crossref","unstructured":"Santarriaga S, Luecke I, Ebert AD. Detection of soluble and insoluble protein species in patient-derived iPSCs. In Stem Cell Assays: Methods and Protocols. Springer; 2022: 73\u201384","DOI":"10.1007\/978-1-0716-1979-7_6"},{"key":"734_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jprot.2014.09.030","volume":"118","author":"AM Crowell","year":"2015","unstructured":"Crowell AM, MacLellan DL, Doucette AA. A two-stage spin cartridge for integrated protein precipitation, digestion and SDS removal in a comparative bottom-up proteomics workflow. J Proteomics. 2015;118:140\u201350.","journal-title":"J Proteomics"},{"key":"734_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/acs.analchem.1c03338","volume":"94","author":"D Mehta","year":"2022","unstructured":"Mehta D, Scandola S, Uhrig RG. BoxCar and Library-Free Data-Independent Acquisition Substantially Improve the Depth, Range, and Completeness of Label-Free Quantitative Proteomics. Anal Chem. 2022;94:793\u2013802.","journal-title":"Anal Chem"},{"key":"734_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","volume":"9","author":"A Sobue","year":"2021","unstructured":"Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido TC, Sahara N. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9:1\u201317.","journal-title":"Acta Neuropathol Commun"},{"issue":"253\u2013271","key":"734_CR27","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh J. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(253\u2013271): e256.","journal-title":"Immunity"},{"key":"734_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19:15.","journal-title":"Genome Biol"},{"key":"734_CR29","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47:W191\u20138.","journal-title":"Nucleic Acids Res"},{"key":"734_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089454","volume":"9","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S, Haertel C, Maelicke A, Montag D. Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer\u2019s disease. PLoS ONE. 2014;9: e89454.","journal-title":"PLoS ONE"},{"key":"734_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biopsych.2021.02.968","volume":"91","author":"L Guo","year":"2022","unstructured":"Guo L, Zhong MB, Zhang L, Zhang B, Cai D. Sex differences in Alzheimer\u2019s disease: Insights from the multiomics landscape. Biol Psychiat. 2022;91:61\u201371.","journal-title":"Biol Psychiat"},{"key":"734_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.713726","volume":"13","author":"AL Oblak","year":"2021","unstructured":"Oblak AL, Lin PB, Kotredes KP, Pandey RS, Garceau D, Williams HM, Uyar A, O\u2019Rourke R, O\u2019Rourke S, Ingraham C. Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Frontiers in aging neuroscience. 2021;13: 713726.","journal-title":"Frontiers in aging neuroscience"},{"key":"734_CR33","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:3758.","journal-title":"Nat Commun"},{"key":"734_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01251-1","volume":"9","author":"AT Delizannis","year":"2021","unstructured":"Delizannis AT, Nonneman A, Tsering W, De Bondt A, Van den Wyngaert I, Zhang B, Meymand E, Olufemi MF, Koivula P, Maimaiti S. Effects of microglial depletion and TREM2 deficiency on A\u03b2 plaque burden and neuritic plaque tau pathology in 5XFAD mice. Acta Neuropathol Commun. 2021;9:1\u201319.","journal-title":"Acta Neuropathol Commun"},{"key":"734_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9440(10)63360-3","volume":"165","author":"T Bussi\u00e8re","year":"2004","unstructured":"Bussi\u00e8re T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive A\u03b2 immunotherapy on their clearance. Am J Pathol. 2004;165:987\u201395.","journal-title":"Am J Pathol"},{"key":"734_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/10520290903389445","volume":"85","author":"M D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea M, Nagele R. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer\u2019s disease pathogenesis. Biotech Histochem. 2010;85:133\u201347.","journal-title":"Biotech Histochem"},{"key":"734_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:1\u201318.","journal-title":"Mol Neurodegener"},{"key":"734_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053587","volume":"8","author":"J Dumurgier","year":"2013","unstructured":"Dumurgier J, Mouton-Liger F, Lapalus P, Prevot M, Laplanche J-L, Hugon J, Paquet C. Network GdIdLCS: Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer\u2019s disease. PLoS ONE. 2013;8: e53587.","journal-title":"PLoS ONE"},{"key":"734_CR39","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1038\/s41598-018-21641-1","volume":"8","author":"G Di Fede","year":"2018","unstructured":"Di Fede G, Catania M, Maderna E, Ghidoni R, Benussi L, Tonoli E, Giaccone G, Moda F, Paterlini A, Campagnani I. Molecular subtypes of Alzheimer\u2019s disease. Sci Rep. 2018;8:3269.","journal-title":"Sci Rep"},{"key":"734_CR40","doi-asserted-by":"publisher","first-page":"14488","DOI":"10.1523\/JNEUROSCI.3088-11.2011","volume":"31","author":"F Langer","year":"2011","unstructured":"Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M. Soluble A\u03b2 seeds are potent inducers of cerebral \u03b2-amyloid deposition. J Neurosci. 2011;31:14488\u201395.","journal-title":"J Neurosci"},{"key":"734_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-021-01187-6","volume":"9","author":"A Ruiz-Riquelme","year":"2021","unstructured":"Ruiz-Riquelme A, Mao A, Barghash MM, Lau HH, Stuart E, Kovacs GG, Nilsson KPR, Fraser PE, Schmitt-Ulms G, Watts JC. A\u03b243 aggregates exhibit enhanced prion-like seeding activity in mice. Acta Neuropathol Commun. 2021;9:83.","journal-title":"Acta Neuropathol Commun"},{"key":"734_CR42","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, Zhou Y, Reinartz M, Choi S, Jiang H, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"734_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78:631\u201343.","journal-title":"Neuron"},{"key":"734_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1742-2094-8-174","volume":"8","author":"C Perego","year":"2011","unstructured":"Perego C, Fumagalli S, De Simoni MG. Temporal pattern of expression and colocalization of microglia\/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation. 2011;8:174.","journal-title":"J Neuroinflammation"},{"key":"734_CR45","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"key":"734_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, Nimmerjahn A, Lemke G. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"734_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"734_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/alz.050403","volume":"17","author":"N Villacampa","year":"2021","unstructured":"Villacampa N, Sarlus H, Martorell P, Slutzkin I, Mcmanus RM, Beyer M, Segal E, Heneka MT. Proliferating microglia exhibit unique transcriptomal and functional alterations in Alzheimer\u2019s disease. Alzheimers Dement. 2021;17: e050403.","journal-title":"Alzheimers Dement"},{"key":"734_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705581","volume":"12","author":"S Estfanous","year":"2021","unstructured":"Estfanous S, Daily KP, Eltobgy M, Deems NP, Anne MN, Krause K, Badr A, Hamilton K, Carafice C, Hegazi A. Elevated expression of MiR-17 in microglia of Alzheimer\u2019s disease patients abrogates autophagy-mediated amyloid-\u03b2 degradation. Front Immunol. 2021;12: 705581.","journal-title":"Front Immunol"},{"key":"734_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0816-7","volume":"14","author":"S Krishnasamy","year":"2017","unstructured":"Krishnasamy S, Weng Y-C, Thammisetty SS, Phaneuf D, Lalancette-Hebert M, Kriz J. Molecular imaging of nestin in neuroinflammatory conditions reveals marked signal induction in activated microglia. J Neuroinflammation. 2017;14:1\u201314.","journal-title":"J Neuroinflammation"},{"key":"734_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13375","volume":"20","author":"C Gu","year":"2021","unstructured":"Gu C, Wang F, Zhang YT, Wei SZ, Liu JY, Sun HY, Wang GH, Liu CF. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20: e13375.","journal-title":"Aging Cell"},{"key":"734_CR52","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41467-020-15770-3","volume":"11","author":"X Guo","year":"2020","unstructured":"Guo X, Pan Y, Xiong M, Sanapala S, Anastasaki C, Cobb O, Dahiya S, Gutmann DH. Midkine activation of CD8(+) T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth. Nat Commun. 2020;11:2177.","journal-title":"Nat Commun"},{"key":"734_CR53","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/glia.23976","volume":"69","author":"WA Campbell","year":"2021","unstructured":"Campbell WA, Fritsch-Kelleher A, Palazzo I, Hoang T, Blackshaw S, Fischer AJ. Midkine is neuroprotective and influences glial reactivity and the formation of Muller glia-derived progenitor cells in chick and mouse retinas. Glia. 2021;69:1515\u201339.","journal-title":"Glia"},{"key":"734_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.32499","volume":"174","author":"AC Naj","year":"2017","unstructured":"Naj AC, Schellenberg GD. Alzheimer\u2019s Disease Genetics C: Genomic variants, genes, and pathways of Alzheimer\u2019s disease: An overview. Am J Med Genet B Neuropsychiatr Genet. 2017;174:5\u201326.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"734_CR55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jnen\/nlad006","volume":"82","author":"M An","year":"2023","unstructured":"An M, Qiu Y, Wang C, Ma P, Ding Y. Rac2 enhances activation of microglia and astrocytes, inflammatory response, and apoptosis via activating JNK signaling pathway and suppressing SIRT1 expression in chronic constriction injury-induced neuropathic pain. J Neuropathol Exp Neurol. 2023;82:419\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"734_CR56","first-page":"e20201879","volume":"219","author":"M Cornille","year":"2022","unstructured":"Cornille M, Moriceau S, Khonsari RH, Heuze Y, Loisay L, Boitez V, Morice A, Arnaud E, Collet C, Bensidhoum M, et al. FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model. J Exp Med. 2022;219(4):e20201879.","journal-title":"J Exp Med."},{"key":"734_CR57","doi-asserted-by":"crossref","unstructured":"Kerrigan TL, Randall AD: A new player in the \"synaptopathy\" of Alzheimer's disease - arc\/arg 3.1. Front Neurol 2013, 4:9.","DOI":"10.3389\/fneur.2013.00009"},{"key":"734_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer\u2019s disease: Targeting the Cholinergic System. Curr Neuropharmacol. 2016;14:101\u201315.","journal-title":"Curr Neuropharmacol"},{"key":"734_CR59","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, Vandamme N, De Schepper S, Van Isterdael G, Scott CL, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019;22:1021\u201335.","journal-title":"Nat Neurosci"},{"issue":"380\u2013395","key":"734_CR60","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, Lelios I, Heppner FL, Kipnis J, Merkler D, et al. High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. Immunity. 2018;48(380\u2013395): e386.","journal-title":"Immunity"},{"issue":"6425","key":"734_CR61","doi-asserted-by":"publisher","first-page":"eaat7554","DOI":"10.1126\/science.aat7554","volume":"363","author":"MJC Jordao","year":"2019","unstructured":"Jordao MJC, Sankowski R, Brendecke SM, Sagar, Locatelli G, Tai YH, Tay TL, Schramm E, Armbruster S, Hagemeyer N, et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science. 2019;363(6425):eaat7554.","journal-title":"Science"},{"key":"734_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, Overhoff K, Steixner-Kumar AA, Subramanian S, Arinrad S, et al. Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer\u2019s disease. Nature. 2023;618:349\u201357.","journal-title":"Nature"},{"issue":"2292\u20132307","key":"734_CR63","volume":"109","author":"J-F Chen","year":"2021","unstructured":"Chen J-F, Liu K, Hu B, Li R-R, Xin W, Chen H, Wang F, Chen L, Li R-X, Ren S-Y. Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease. Neuron. 2021;109(2292\u20132307): e2295.","journal-title":"Neuron"},{"key":"734_CR64","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B. Wan Y-w, Chiu G, Cole A, Yin Z, Propson NE, Xu Y, Jankowsky JL, Liu Z: Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Investig. 2020;130:1912\u201330.","journal-title":"J Clin Investig"},{"issue":"879\u2013894","key":"734_CR65","volume":"55","author":"ER Roy","year":"2022","unstructured":"Roy ER, Chiu G, Li S, Propson NE, Kanchi R, Wang B, Coarfa C, Zheng H, Cao W. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid \u03b2 plaques. Immunity. 2022;55(879\u2013894): e876.","journal-title":"Immunity"},{"issue":"13","key":"734_CR66","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.neuron.2023.04.006","volume":"111","author":"BP Festa","year":"2023","unstructured":"Festa BP, Siddiqi FH, Jimenez-Sanchez M, Won H, Rob M, Djajadikerta A, Stamatakou E, Rubinsztein DC. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron. 2023;111(13):2021\u20132037.e12.","journal-title":"Neuron"},{"key":"734_CR67","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell. 2018;173:1073\u201381.","journal-title":"Cell"},{"key":"734_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022408","volume":"6","author":"SG Wohl","year":"2011","unstructured":"Wohl SG, Schmeer CW, Friese T, Witte OW, Isenmann S. In situ dividing and phagocytosing retinal microglia express nestin, vimentin, and NG2 in vivo. PLoS ONE. 2011;6: e22408.","journal-title":"PLoS ONE"},{"key":"734_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2009.03.014","volume":"1270","author":"Y Takamori","year":"2009","unstructured":"Takamori Y, Mori T, Wakabayashi T, Nagasaka Y, Matsuzaki T, Yamada H. Nestin-positive microglia in adult rat cerebral cortex. Brain Res. 2009;1270:10\u20138.","journal-title":"Brain Res"},{"issue":"566\u2013581","key":"734_CR70","first-page":"e569","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L. O\u2019loughlin E, Xu Y, Fanek Z: The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(566\u2013581)e569.","journal-title":"Immunity"},{"key":"734_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00584-2","volume":"17","author":"S Zia","year":"2022","unstructured":"Zia S, Hammond BP, Zirngibl M, Sizov A, Baaklini CS, Panda SP, Ho MF, Lee KV, Mainali A, Burr MK. Single-cell microglial transcriptomics during demyelination defines a microglial state required for lytic carcass clearance. Mol Neurodegener. 2022;17:1\u201324.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"734_CR72","doi-asserted-by":"publisher","first-page":"e20220605","DOI":"10.1084\/jem.20220605","volume":"220","author":"RT Han","year":"2023","unstructured":"Han RT, Vainchtein ID, Schlachetzki JCM, Cho FS, Dorman LC, Ahn E, Kim DK, Barron JJ, Nakao-Inoue H, Molofsky AB, et al. Microglial pattern recognition via IL-33 promotes synaptic refinement in developing corticothalamic circuits in mice. J Exp Med. 2023;220(2):e20220605.","journal-title":"J Exp Med."},{"key":"734_CR73","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1523\/JNEUROSCI.1871-19.2019","volume":"40","author":"WJ Meilandt","year":"2020","unstructured":"Meilandt WJ, Ngu H, Gogineni A, Lalehzadeh G, Lee S-H, Srinivasan K, Imperio J, Wu T, Weber M, Kruse AJ. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the A\u03b242: A\u03b240 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J Neurosci. 2020;40:1956\u201374.","journal-title":"J Neurosci"},{"key":"734_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Pr\u00e9vot V, Nicholson DA, Thinakaran G, Vassar R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease. Acta Neuropathol. 2016;132:235\u201356.","journal-title":"Acta Neuropathol"},{"key":"734_CR75","doi-asserted-by":"crossref","unstructured":"Seibenhener ML, Wooten MC: Use of the open field maze to measure locomotor and anxiety-like behavior in mice. Journal of visualized experiments: JoVE 2015.","DOI":"10.3791\/52434-v"},{"key":"734_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","volume":"463","author":"M Bourin","year":"2003","unstructured":"Bourin M, Hascoet M. The mouse light\/dark box test. Eur J Pharmacol. 2003;463:55\u201365.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"734_CR77","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","volume":"35","author":"AC Campos","year":"2013","unstructured":"Campos AC, Fogaca MV, Aguiar DC, Guimaraes FS. Animal models of anxiety disorders and stress. Braz J Psychiatry. 2013;35(Suppl 2):S101\u2013111.","journal-title":"Braz J Psychiatry"},{"key":"734_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. Methods Mol Biol. 2019;1916:105\u201311.","journal-title":"Methods Mol Biol"},{"key":"734_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","volume":"26","author":"R Lalonde","year":"2002","unstructured":"Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev. 2002;26:91\u2013104.","journal-title":"Neurosci Biobehav Rev"},{"key":"734_CR80","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I. Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. The American Journal of Human Genetics. 2008;83:623\u201332.","journal-title":"The American Journal of Human Genetics"},{"key":"734_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS ONE. 2012;7: e50976.","journal-title":"PLoS ONE"},{"key":"734_CR82","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1128\/MCB.23.12.4199-4206.2003","volume":"23","author":"Brinkman-Van der Linden EC","year":"2003","unstructured":"Brinkman-Van der Linden EC. Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A: CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol. 2003;23:4199\u2013206.","journal-title":"Mol Cell Biol"},{"key":"734_CR83","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1093\/hmg\/ddv092","volume":"24","author":"M Malik","year":"2015","unstructured":"Malik M, Chiles J III, Xi HS, Medway C, Simpson J, Potluri S, Howard D, Liang Y, Paumi CM, Mukherjee S. Genetics of CD33 in Alzheimer\u2019s disease and acute myeloid leukemia. Hum Mol Genet. 2015;24:3557\u201370.","journal-title":"Hum Mol Genet"},{"key":"734_CR84","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1080\/10428194.2019.1569232","volume":"60","author":"I Papageorgiou","year":"2019","unstructured":"Papageorgiou I, Loken MR, Brodersen LE, Gbadamosi M, Uy GL, Meshinchi S, Lamba JK. CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents. Leuk Lymphoma. 2019;60:2287\u201390.","journal-title":"Leuk Lymphoma"},{"issue":"820\u2013835","key":"734_CR85","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, Cereghetti G, McGinty D, Anselmo A, Sadreyev RI. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103(820\u2013835): e827.","journal-title":"Neuron"},{"key":"734_CR86","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nn.4126","volume":"18","author":"G Chan","year":"2015","unstructured":"Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015;18:1556\u20138.","journal-title":"Nat Neurosci"},{"key":"734_CR87","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade A, Kang YJ, Hasselmann J, Jairaman A, Sotelo A, Coburn M, Shabestari SK, Chadarevian JP, Fote G, Tu CH. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun. 2020;11:5370.","journal-title":"Nat Commun"},{"key":"734_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu Y, Fryatt GL, Ghorbani M, Obst J, Menassa DA, Martin-Estebane M, Muntslag TA, Olmos-Alonso A, Guerrero-Carrasco M, Thomas D. Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology. Cell Rep. 2021;35: 109228.","journal-title":"Cell Rep"},{"key":"734_CR89","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit WJ, Braak H, Xue Q-S, Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol. 2009;118:475\u201385.","journal-title":"Acta Neuropathol"},{"key":"734_CR90","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/alz.12523","volume":"18","author":"TR Hawkinson","year":"2022","unstructured":"Hawkinson TR, Clarke HA, Young LE, Conroy LR, Markussen KH, Kerch KM, Johnson LA, Nelson PT, Wang C, Allison DB. In situ spatial glycomic imaging of mouse and human Alzheimer\u2019s disease brains. Alzheimers Dement. 2022;18:1721\u201335.","journal-title":"Alzheimers Dement"},{"key":"734_CR91","doi-asserted-by":"crossref","unstructured":"Peng W, Kobeissy F, Mondello S, Barsa C, Mechref Y: MS-based glycomics: An analytical tool to assess nervous system diseases. Frontiers in Neuroscience 2022, 16.","DOI":"10.3389\/fnins.2022.1000179"},{"issue":"12","key":"734_CR92","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.mcpro.2022.100433","volume":"21","author":"S Suttapitugsakul","year":"2022","unstructured":"Suttapitugsakul S, Stavenhagen K, Donskaya S, Bennett DA, Mealer RG, Seyfried NT, Cummings RD. Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer\u2019s Disease Brain. Mol Cell Proteomics. 2022;21(12):100433.","journal-title":"Mol Cell Proteomics"},{"key":"734_CR93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026102118","volume":"118","author":"C B\u00fcll","year":"2021","unstructured":"B\u00fcll C, Nason R, Sun L, Van Coillie J, Madriz S\u00f8rensen D, Moons SJ, Yang Z, Arbitman S, Fernandes SM, Furukawa S. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc Natl Acad Sci. 2021;118: e2026102118.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"734_CR94","doi-asserted-by":"publisher","first-page":"101960","DOI":"10.1016\/j.jbc.2022.101960","volume":"298","author":"A Gonzalez-Gil","year":"2022","unstructured":"Gonzalez-Gil A, Porell RN, Fernandes SM, Maenpaa E, Li TA, Li T, Wong PC, Aoki K, Tiemeyer M, Zaikuan JY. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer\u2019s disease. J Biol Chem. 2022;298(6):101960.","journal-title":"J Biol Chem"},{"key":"734_CR95","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1021\/acschembio.1c00501","volume":"16","author":"J Jung","year":"2021","unstructured":"Jung J, Enterina JR, Bui DT, Mozaneh F, Lin P-H. Nitin, Kuo C-W, Rodrigues E, Bhattacherjee A, Raeisimakiani P: Carbohydrate sulfation as a mechanism for fine-tuning Siglec ligands. ACS Chem Biol. 2021;16:2673\u201389.","journal-title":"ACS Chem Biol"},{"key":"734_CR96","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41467-020-18907-6","volume":"11","author":"E Rodrigues","year":"2020","unstructured":"Rodrigues E, Jung J, Park H, Loo C, Soukhtehzari S, Kitova EN, Mozaneh F, Daskhan G, Schmidt EN, Aghanya V. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands. Nat Commun. 2020;11:5091.","journal-title":"Nat Commun"},{"key":"734_CR97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, Nimmerjahn A, Lemke G. Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"734_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, et al. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"734_CR99","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/s41467-021-25344-6","volume":"12","author":"R Bassil","year":"2021","unstructured":"Bassil R, Shields K, Granger K, Zein I, Ng S, Chih B. Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. Nat Commun. 2021;12:5220.","journal-title":"Nat Commun"},{"key":"734_CR100","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","volume":"21","author":"Y Huang","year":"2018","unstructured":"Huang Y, Xu Z, Xiong S, Sun F, Qin G, Hu G, Wang J, Zhao L, Liang Y-X, Wu T. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nat Neurosci. 2018;21:530\u201340.","journal-title":"Nat Neurosci"},{"key":"734_CR101","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.15252\/embj.201696056","volume":"36","author":"A Wlodarczyk","year":"2017","unstructured":"Wlodarczyk A, Holtman IR, Krueger M, Yogev N, Bruttger J, Khorooshi R, Benmamar-Badel A, de Boer-Bergsma JJ, Martin NA, Karram K. A novel microglial subset plays a key role in myelinogenesis in developing brain. EMBO J. 2017;36:3292\u2013308.","journal-title":"EMBO J"},{"key":"734_CR102","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1074\/jbc.M117.799346","volume":"292","author":"SS Siddiqui","year":"2017","unstructured":"Siddiqui SS, Springer SA, Verhagen A, Sundaramurthy V, Alisson-Silva F, Jiang W, Ghosh P, Varki A. The Alzheimer\u2019s disease\u2013protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool. J Biol Chem. 2017;292:15312\u201320.","journal-title":"J Biol Chem"},{"key":"734_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis. 2020;142: 104956.","journal-title":"Neurobiol Dis"},{"key":"734_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.003","volume":"61","author":"EE Spangenberg","year":"2017","unstructured":"Spangenberg EE, Green KN. Inflammation in Alzheimer\u2019s disease: lessons learned from microglia-depletion models. Brain Behav Immun. 2017;61:1\u201311.","journal-title":"Brain Behav Immun"},{"key":"734_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110961","volume":"39","author":"SK Shabestari","year":"2022","unstructured":"Shabestari SK, Morabito S, Danhash EP, McQuade A, Sanchez JR, Miyoshi E, Chadarevian JP, Claes C, Coburn MA, Hasselmann J. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep. 2022;39: 110961.","journal-title":"Cell Rep"},{"key":"734_CR106","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D, Grutzendler J. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"734_CR107","unstructured":"Walker LC: A\u03b2 plaques. Free neuropathology 2020, 1."},{"key":"734_CR108","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jmb.2019.01.045","volume":"431","author":"A McQuade","year":"2019","unstructured":"McQuade A, Blurton-Jones M. Microglia in Alzheimer\u2019s disease: exploring how genetics and phenotype influence risk. J Mol Biol. 2019;431:1805\u201317.","journal-title":"J Mol Biol"},{"key":"734_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflammation. 2021;18:1\u201318.","journal-title":"J Neuroinflammation"},{"key":"734_CR110","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G, Pettkus N, Brunner B. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region. EMBO Mol Med. 2020;12: e11227.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"734_CR111","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M, Hummel S, Lianoglou S. A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26(3):416\u201329.","journal-title":"Nat Neurosci"},{"issue":"9","key":"734_CR112","doi-asserted-by":"publisher","first-page":"e20200785","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217(9):e20200785.","journal-title":"J Exp Med"},{"key":"734_CR113","doi-asserted-by":"crossref","first-page":"e00568","DOI":"10.1128\/MCB.00568-18","volume":"39","author":"P van Bergeijk","year":"2019","unstructured":"van Bergeijk P, Seneviratne U, Aparicio-Prat E, Stanton R, Hasson SA. SRSF1 and PTBP1 are trans-acting factors that suppress the formation of a CD33 splicing isoform linked to Alzheimer\u2019s disease risk. Mol Cell Biol. 2019;39:e00568\u2013e518.","journal-title":"Mol Cell Biol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-024-00734-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T01:03:47Z","timestamp":1716771827000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-024-00734-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s13024-024-00734-8","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approvals are in place for all the animal work carried out in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no conflicts of interest to declare. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}